TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biogen Sweden AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
646,870
|
643,769
|
745,245 |
Financial expenses |
82
|
403
|
832 |
Earnings before taxes |
24,796
|
22,698
|
36,646 |
EBITDA |
23,027
|
23,363
|
37,864 |
Total assets |
256,071
|
236,962
|
268,266 |
Current assets |
255,880
|
236,619
|
267,613 |
Current liabilities |
60,949
|
72,384
|
116,977 |
Equity capital |
182,228
|
152,385
|
138,899 |
- share capital |
101
|
95
|
98 |
Employees (average) |
28
|
31
![]() |
31 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
71.2%
|
64.3%
|
51.8% |
Turnover per employee |
23,102
|
20,767
|
24,040 |
Profit as a percentage of turnover |
3.8%
|
3.5%
|
4.9% |
Return on assets (ROA) |
9.7%
![]() |
9.7%
|
14.0% |
Current ratio |
419.8%
|
326.9%
|
228.8% |
Return on equity (ROE) |
13.6%
|
14.9%
|
26.4% |
Change turnover |
-42,579
|
-79,078
|
94,773 |
Change turnover % |
-6%
|
-11%
|
15% |
Chg. No. of employees |
-3
|
0
|
-2 |
Chg. No. of employees % |
-10%
|
0%
|
-6% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.